Whalegun
Home

Kamal Hamed, Chief Medical Officer: Spero Therapeutics SPRO Sell · Filed 23/09/15

Trade details

Type
Insider sale
Amount
$50,159.92
Shares · price
39,496 sh · $1.27 a share
Held after
576,461 sh
Stock
Spero Therapeutics SPRO
Person
Kamal HamedChief Medical Officer
Trade date
23/09/13
Filed
23/09/15
Days to filing
2 days

Sold 6.4% of holdings

Share of holding sold
6.4%

Spero Therapeutics trades, last 26 weeks

What else happened in Spero Therapeutics around then

Filed or reported within 30 days of the trade day · 23/08/14~23/10/13

Kamal Hamed's recent trades

  • Kamal Hamed

    SellSpero Therapeutics

    $38.5K

    Filed 24/02/05

Kamal Hamed, Chief Officer — sold $50.2K of Spero Therapeutics SPRO · 6.4% of holdings | Whalegun